Rosetta Genomics Ltd. 3,750,000 Ordinary Shares* Underwriting AgreementUnderwriting Agreement • January 23rd, 2007 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 23rd, 2007 Company Industry Jurisdiction
CONFIDENTIAL Non-Exclusive License AgreementNon-Exclusive License Agreement • January 23rd, 2007 • Rosetta Genomics Ltd. • Pharmaceutical preparations
Contract Type FiledJanuary 23rd, 2007 Company IndustryThis agreement (the “Agreement”) is by and between Max-Planck-Innovation GmbH, a German corporation having a principal place of business at Marstallstr. 8, 80539 Muenchen, Germany (“MI”), and Rosetta Genomics Ltd., an Israeli corporation having a principal place of business at 10 Plaut Street, Science Park, Rehovot 76706, Israel (“COMPANY”). This Agreement will become effective on December 22, 2006 (the “Effective Date”).
COOPERATION AND PROJECT FUNDING AGREEMENTCooperation and Project Funding Agreement • January 23rd, 2007 • Rosetta Genomics Ltd. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 23rd, 2007 Company Industry JurisdictionThe ISRAEL-UNITED STATES BINATIONAL INDUSTRIAL RESEARCH AND DEVELOPMENT FOUNDATION, a legal entity created by Agreement between the Government of the State of Israel and the Government of the United States of America (hereinafter referred to as the "Foundation"),